In Light of Vioxx, Bextra Getting A Closer Look

With the pain of the Vioxx recall still fresh, earlier today Pfizer announced earlier today it will conduct long-term cardiovascular safety tests on its pain drug Bextra. Although Bextra hasn't led to higher rates of cardiovascular side effects in studies of the drug on people with osteoarthritis and rheumatoid arthritis, researchers found high-risk patients who had coronary bypass surgery and had taken Bextra for up to a year suffered an increased risk of strokes and heart attacks...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports